Thursday, July 21, 2016

BRIEF-Amgen and UCB submit biologics license application for romosozumab to the FDA

* Amgen and UCB submit biologics license application for

romosozumab to the FDA

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)